ClinVar Miner

Submissions for variant NM_006502.3(POLH):c.490G>T (p.Glu164Ter)

gnomAD frequency: 0.00002  dbSNP: rs767433001
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center RCV000251879 SCV000267456 likely pathogenic Xeroderma pigmentosum variant type 2016-03-18 criteria provided, single submitter reference population
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV001195542 SCV001365923 pathogenic Xeroderma pigmentosum 2019-06-16 criteria provided, single submitter clinical testing The p.Glu164X variant in POLH has been reported in 9 homozygotes and 2 compound heterozygous individuals with Xeroderma pigmentosum variant type (XP-V) (Tanioka 2007, Inui 2008, Masaki 2008). It has also been identified in 0.03% (5/18392) of East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org) and has been reported in ClinVar (Variation ID: 225444). Although this is a nonsense variant, it is located in the last three bases of the exon, which is part of the 5’ splice region. Computational tools and in vitro splicing studies are consistent with pathogenicity (Tanioka 2007, Inui 2008). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive XP-V. ACMG/AMP Criteria applied: PVS1_Strong, PM3_Strong, PS3_Supporting.
Labcorp Genetics (formerly Invitae), Labcorp RCV003556274 SCV004293647 pathogenic not provided 2023-07-16 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Glu164*) in the POLH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLH are known to be pathogenic (PMID: 11773631, 24130121, 25256075). This variant is present in population databases (rs767433001, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 17344931). ClinVar contains an entry for this variant (Variation ID: 225444). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
GeneReviews RCV000251879 SCV000320714 not provided Xeroderma pigmentosum variant type no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.